University of California San Francisco

Makda Zewde
Makda Zewde, MD, MS

Resident (PGY-3) 
General Surgery

[email protected]

Education

Institution Degree Dept or School End Date
Icahn School of Medicine at Mount Sinai MD Doctor of Medicine 05/2023
Northwestern University MS Biostatistics 06/2019
Ithaca College BS Biology 05/2015

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 17
  1. Oncologic outcomes following transanal total mesorectal excision: the United States experience.
    Zewde MG, Peyser DK, Yu AT, Bonaccorso A, Moshier E, Alavi K, Goldstone R, Marks JH, Maykel JA, McLemore EC, Sands D, Steele SR, Wexner SD, Whiteford M, Sylla P| | PubMed
  2. Surgical management of pancreatic ductal adenocarcinoma: a narrative review.
    Sarfaty E, Khajoueinejad N, Zewde MG, Yu AT, Cohen NA| | PubMed
  3. Methodological Considerations on COVID-19 Mortality in Cancer Patients: A Systematic Review and Meta-Analysis.
    Zewde MG, Alpert N, Taioli E| | PubMed
  4. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
    Zewde MG, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, Etra A, Grupp S, Hexner EO, Hogan W, Javorniczky NR, Kasikis S, Kitko CL, Kowalyk S, Meedt E, Merli P, Nakamura R, Qayed M, Reshef R, Rösler W, Schechter T, Weber D, Wölfl M, Yanik G, Young R, Levine JE, Ferrara JLM, Chen YB| | PubMed
  5. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
    Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K| | PubMed
  6. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
    Saloura V, Vougiouklakis T, Bao R, Kim S, Baek S, Zewde M, Bernard B, Burkitt K, Nigam N, Izumchenko E, Dohmae N, Hamamoto R, Nakamura Y| | PubMed
  7. A whole-tissue RNA-seq toolkit for organism-wide studies of gene expression with PME-seq.
    Pandey S, Takahama M, Gruenbaum A, Zewde M, Cheronis K, Chevrier N| | PubMed
  8. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
    Unruh D, Zewde M, Buss A, Drumm MR, Tran AN, Scholtens DM, Horbinski C| | PubMed
  9. TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
    Matsuda T, Miyauchi E, Hsu YW, Nagayama S, Kiyotani K, Zewde M, Park JH, Kato T, Harada M, Matsui S, Ueno M, Fukuda K, Suzuki N, Hazama S, Nagano H, Takeuchi H, Vigneswaran WT, Kitagawa Y, Nakamura Y| | PubMed
  10. The era of immunogenomics/immunopharmacogenomics.
    Zewde M, Kiyotani K, Park JH, Fang H, Yap KL, Yew PY, Alachkar H, Kato T, Mai TH, Ikeda Y, Matsuda T, Liu X, Ren L, Deng B, Harada M, Nakamura Y| | PubMed
17
View all 17 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 17
  1. Oncologic outcomes following transanal total mesorectal excision: the United States experience.
    Zewde MG, Peyser DK, Yu AT, Bonaccorso A, Moshier E, Alavi K, Goldstone R, Marks JH, Maykel JA, McLemore EC, Sands D, Steele SR, Wexner SD, Whiteford M, Sylla P| | PubMed
  2. Surgical management of pancreatic ductal adenocarcinoma: a narrative review.
    Sarfaty E, Khajoueinejad N, Zewde MG, Yu AT, Cohen NA| | PubMed
  3. Methodological Considerations on COVID-19 Mortality in Cancer Patients: A Systematic Review and Meta-Analysis.
    Zewde MG, Alpert N, Taioli E| | PubMed
  4. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
    Zewde MG, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, Etra A, Grupp S, Hexner EO, Hogan W, Javorniczky NR, Kasikis S, Kitko CL, Kowalyk S, Meedt E, Merli P, Nakamura R, Qayed M, Reshef R, Rösler W, Schechter T, Weber D, Wölfl M, Yanik G, Young R, Levine JE, Ferrara JLM, Chen YB| | PubMed
  5. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
    Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K| | PubMed
  6. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
    Saloura V, Vougiouklakis T, Bao R, Kim S, Baek S, Zewde M, Bernard B, Burkitt K, Nigam N, Izumchenko E, Dohmae N, Hamamoto R, Nakamura Y| | PubMed
  7. A whole-tissue RNA-seq toolkit for organism-wide studies of gene expression with PME-seq.
    Pandey S, Takahama M, Gruenbaum A, Zewde M, Cheronis K, Chevrier N| | PubMed
  8. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
    Unruh D, Zewde M, Buss A, Drumm MR, Tran AN, Scholtens DM, Horbinski C| | PubMed
  9. TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
    Matsuda T, Miyauchi E, Hsu YW, Nagayama S, Kiyotani K, Zewde M, Park JH, Kato T, Harada M, Matsui S, Ueno M, Fukuda K, Suzuki N, Hazama S, Nagano H, Takeuchi H, Vigneswaran WT, Kitagawa Y, Nakamura Y| | PubMed
  10. The era of immunogenomics/immunopharmacogenomics.
    Zewde M, Kiyotani K, Park JH, Fang H, Yap KL, Yew PY, Alachkar H, Kato T, Mai TH, Ikeda Y, Matsuda T, Liu X, Ren L, Deng B, Harada M, Nakamura Y| | PubMed
  11. Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
    Kato T, Matsuda T, Ikeda Y, Park JH, Leisegang M, Yoshimura S, Hikichi T, Harada M, Zewde M, Sato S, Hasegawa K, Kiyotani K, Nakamura Y| | PubMed
  12. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Saloura V, Fatima A, Zewde M, Kiyotani K, Brisson R, Park JH, Ikeda Y, Vougiouklakis T, Bao R, Khattri A, Seiwert T, Cipriani N, Lingen M, Vokes E, Nakamura Y| | PubMed
  13. TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
    Park JH, Inoue H, Kato T, Zewde M, Miyamoto T, Matsuo Y, Salgia R, Nakamura Y| | PubMed
  14. WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
    Saloura V, Vougiouklakis T, Zewde M, Deng X, Kiyotani K, Park JH, Matsuo Y, Lingen M, Suzuki T, Dohmae N, Hamamoto R, Nakamura Y| | PubMed
  15. Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma.
    Kiyotani K, Park JH, Inoue H, Husain A, Olugbile S, Zewde M, Nakamura Y, Vigneswaran WT| | PubMed
  16. WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.
    Saloura V, Vougiouklakis T, Zewde M, Kiyotani K, Park JH, Gao G, Karrison T, Lingen M, Nakamura Y, Hamamoto R| | PubMed
  17. Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.
    Inoue H, Park JH, Kiyotani K, Zewde M, Miyashita A, Jinnin M, Kiniwa Y, Okuyama R, Tanaka R, Fujisawa Y, Kato H, Morita A, Asai J, Katoh N, Yokota K, Akiyama M, Ihn H, Fukushima S, Nakamura Y| | PubMed